BDSX News and Press, Biodesix Inc. From 04/27/22

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that it will release financial results for the first quarter ended March 31, 2022 before the open of trading on Wednesday, May 11. Biodesix’s manage...

Biodesix (NASDAQ:BDSX) stock rose ~8% on April 20 after Cowen initiated coverage of the company with an Outperform rating and no price target. Analyst Max Masucci believes the company's $44M market capitalization understates the value of its core intellectual property and liquid biopsy t...

Clarus Therapeutics (CRXT) +18%. AlloVir (ALVR) +18% on FDA regenerative medicine tag for posoleucel to prevent 6 viruses in cell transplant patients. Westwater Resources (WWR) +15%  and Alabama Graphite Products break ground on Kellyton processing plant. IceCure Medical (...

Gainers: Antares Pharma ATRS +49%. Sierra Oncology SRRA +38%. CTI BioPharma (CTIC) +8%. Ikena Oncology IKNA +8%. Modular Medical (MODD) +4%. Losers: NanoString Technologies NSTG -31%. Bio-Path (BPTH) -17%. BioCardia (BCDA) -14%. Biod...

Gainers: Lixte Biotechnology Holdings (LIXT) +205%. PolarityTE (PTE) +96%. Biodesix (BDSX) +29%. MiNK Therapeutics (INKT) +27%. Enservco (ENSV) +25%. Actinium Pharmaceuticals (ATNM) +21%. Compass Therapeutics (CMPX) +21%. Sunshine Biopharma (SBFM) +22%. Singularity Future Technology (SGLY) +2...

Gainers: Lixte Biotechnology LIXT +263%. BioCardia BCDA +29%. Biodesix BDSX +27%. Aeglea BioTherapeutics AGLE +16%. Actinium Pharmaceuticals ATNM +14%. Losers: Hoth Therapeutics HOTH -30%. Altamira Therapeutics CYTO -29%. Myovant Sciences (MYO...

3 Penny Stocks to Watch Ahead of the Stock Market Open Today After a less than stellar day of trading penny stocks on April 11th, investors have high hopes for today. In the past few weeks, anyone who has traded either penny stocks or blue chips is no stranger to volatility. [...

The shares of lung test maker, Biodesix (NASDAQ:BDSX) have climbed ~50% in the pre-market Tuesday in reaction to multiple insider purchases made by certain members of the company management. In regulatory filings submitted on Monday, Biodesix (BDSX) Chairman John Patience and board membe...

NEW YORK, April 12, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: PolarityTE, Inc. (NASDAQ: PTE) Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Biodesix, Inc....

Biodesix (BDSX) +53%. Actinium Pharmaceuticals ATNM +44% on agreement with Immedica Pharma for conditioning agent. BioCardia BCDA +34% after FDA nod to begin trial of BCDA-04 in COVID patients. Aeglea BioTherapeutics AGLE +19% on filing seeking FDA approval of pe...